AngioDynamics, Inc. Restructuring and Related Cost, Cost Incurred to Date
AngioDynamics, Inc. (ANGO) had Restructuring and Related Cost, Cost Incurred to Date of $9.50 million as of 2024-05-31, per its 10-K filed 2024-07-25.
Discontinued › Notes
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2024-07-25
- 2024-05-31: Restructuring and Related Cost, Cost Incurred to Date $9.50M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2024-05-31 | $9.50M 10-K · filed 2024-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |